Role of the cannabinoid system in the transit of beta-amyloid across the blood–brain barrier
Authors:
- Corbin BachmeierCBCorbin Bachmeier
- David Beaulieu-AbdelahadDBDavid Beaulieu-Abdelahad
- Michael MullanMMMichael Mullan
- Daniel ParisDPDaniel Paris
- 1 September 2013
- journal article
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 56, 255-262
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's DiseaseCell Reports, 2012
- Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrierCytotechnology, 2010
- The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptorsNature Neuroscience, 2010
- The endocannabinoid system as a target for the treatment of neurodegenerative diseaseBritish Journal of Pharmacology, 2010
- Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivoProceedings of the National Academy of Sciences, 2009
- Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effectsNature Chemical Biology, 2008
- Alzheimer's disease; taking the edge off with cannabinoids?British Journal of Pharmacology, 2007
- Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptorsBritish Journal of Pharmacology, 2007
- Clearance of amyloid-β by circulating lipoprotein receptorsNature Medicine, 2007
- Endothelium‐dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2‐arachidonoylglycerolBritish Journal of Pharmacology, 2007